Effect of 48‐week pemafibrate on non‐alcoholic fatty liver disease with hypertriglyceridemia, as evaluated by the FibroScan‐ aspartate aminotransferase score
Journal article published in 2021 by
Takeshi Hatanaka 
,
Takashi Kosone,
Naoto Saito,
Satoshi Takakusagi ,
Hiroki Tojima ,
Atsushi Naganuma ,
Hitoshi Takagi ,
Toshio Uraoka ,
Satoru Kakizaki
,
Takashi Kosone,
Naoto Saito,
Satoshi Takakusagi ,
Hiroki Tojima ,
Atsushi Naganuma ,
Hitoshi Takagi ,
Toshio Uraoka ,
Satoru Kakizaki
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 